At ViVE, an Optimistic Look Into Health IT’s Future
ViVE’s leaders predict major health IT breakthroughs on the horizon
Read More
Case study: Weill Cornell increases collections by $15M with Collections Optimization Manager
“Our call strategies did not yield the desired outcomes, and we recognized the need for additional data to better support our goal. We were also mindful of the potential risk of staff burnout and the impact it could have on overall performance.” —Carey Lawrence, Revenue Cycle Administrator Customer Service and Self-Pay Collections, Weill Cornell Medicine…
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria
That is the title of my recent paper with co-authors Denise Clayton, Glorian Yen, Lincy Geevarghese, Yulin Shi Anem Waheed. The abstract is below. IntroductionParoxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease associated with complications that increase morbidity, such as thrombosis and chronic kidney disease. Limited data exist regarding complications among treated patients outside…
California Official Comes out of Retirement To Lead Troubled Mental Health Commission
Veteran California public servant Will Lightbourne has stepped in as interim executive director of the state’s mental health commission after its previous executive director resigned following conflict of interest allegations. Lightbourne served as head of the state’s Department of Social Services for seven years before retiring in 2018 and had already returned to service once,…
Para las farmacéuticas, la pelea entre Trump y Harris es entre dos enemigos de la industria
En medio de una amarga y divisiva contienda, el ex presidente Donald Trump y la vicepresidenta Kamala Harris solo parecen coincidir en una cosa: es tarea del gobierno reducir los altos precios de los medicamentos en el país. En 2022, Harris emitió el voto de desempate en el Senado para aprobar una ley que permite…
Status of State Medicaid Expansion Decisions
This page displays an interactive map of the current status of state decisions on the Affordable Care Act’s Medicaid expansion. Additional Medicaid expansion resources are listed (with links) below the map.
Fluoride Bans and Food Safety Doubts — The Monitor
This Monitor covers how fears about fluoride as a neurotoxin are impacting public health and how trust in food safety is eroding following the USDA’s disbandment of two food safety panels. It also discusses approaches to addressing false information and the accuracy of AI chatbots compared to search engines.
Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics is cutting discovery and preclinical work to focus on its clinical-stage cancer drugs. The most advanced program is camonsertib, whose rights Repare recently regained from Roche after the pharma giant terminated an alliance started in 2022. The post Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline appeared first on MedCity News.
How long does it take new medical research to be adopted by real-world physicians?
Conventional wisdom holds that it takes 17 years from medical innovation to adoption in the real-world. However, with advances in information technology, perhaps adoption timelines have shortened. A paper by DiCicca et al. (2024) examines how new clinical trial evidence on breech births impact practice patterns. Specifically, they note that: Using the United States Birth…
Current, Former CDC Staff Warn Against Slashing Support to Local Public Health Departments
On a sunny weekday in Atlanta, a small crowd of people gathered for a rally outside of a labor union headquarters building. The event, put together by Atlanta-area Democratic U.S. Rep. Nikema Williams, was attended mostly by union members and recently fired federal workers, including Ryan Sloane. “I was fired by an anonymous email at…